A Model-Independent Method to Determine Restricted Mean Survival Time in the Analysis of Survival Curves
Author:
Publisher
Springer Science and Business Media LLC
Link
http://link.springer.com/content/pdf/10.1007/s42399-019-00199-7.pdf
Reference8 articles.
1. Trinquart L, Jacot J, Conner SC, Porcher R. Comparison of treatment effects measured by the hazard ratio and by the ratio of restricted mean survival times in oncology randomized controlled trials. J Clin Oncol. 2016;34(15):1813–9. https://doi.org/10.1200/JCO.2015.64.2488.
2. Royston P, Parmar MK. The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt. Stat Med. 2011;30(19):2409–21. https://doi.org/10.1002/sim.4274.
3. Pharmacokinetics, 2nd Edition by Milo Gibaldi and Donald Perrier. Marcel Dekker, New York, 1982.
4. Matucci M, Messori A, Donati-Cori G, Longo G, Vannini S, Morfini M, et al. Kinetic evaluation of four factor VIII concentrates by model-independent methods. Scand J Haematol. 1985;34:22–8.
5. Damuzzo V, Agnoletto L, Leonardi L, Chiumente M, Mengato D, Messori A. Analysis of survival curves: statistical methods accounting for the presence of long-term survivors. Front Oncol 2019;9:453–9. https://doi.org/10.3389/fonc.2019.00453.
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nonconcurrent Controls in Platform Trials: Can We Borrow Their Concurrent Observation Data?;Statistics in Biopharmaceutical Research;2023-10-05
2. Gamified inoculation interventions do not improve discrimination between true and fake news: Reanalyzing existing research with receiver operating characteristic analysis.;Journal of Experimental Psychology: General;2023-09
3. Testing for Differences in Survival When Treatment Effects Are Persistent, Decaying, or Delayed;Journal of Clinical Oncology;2022-10-20
4. A Toxicologic Review of Quantum Dots: Recent Insights and Future Directions;Application of Quantum Dots in Biology and Medicine;2022
5. Consideration of Surrogate Endpoints for Overall Survival Associated With First-Line Immunotherapy in Extensive-Stage Small Cell Lung Cancer;Frontiers in Oncology;2021-07-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3